Amazon.com's Mechanical Turk (MTurk) website provides a data collection platform with quick and inexpensive access to diverse samples. Numerous reports have lauded MTurk as capturing high-quality data with an epidemiological sample that is more representative of the U.S. population than traditional in-person convenience samples (e.g., undergraduate subject pools). This benefit, in combination with the ease and low-cost of data collection, has led to a remarkable increase in studies using MTurk to investigate phenomena across a wide range of psychological disciplines. Multiple reports have now examined the demographic characteristics of MTurk samples. One key gap remains, however, in that relatively little is known about individual differences in clinical symptoms among MTurk participants. This paper discusses the importance of assessing clinical phenomena in MTurk samples and supports its assertions through an empirical investigation of a large sample (N = 1,098) of MTurk participants. Results revealed that MTurk participants endorse clinical symptoms to a substantially greater degree than traditional nonclinical samples. This distinction was most striking for depression and social anxiety symptoms, which were endorsed at levels comparable with individuals with clinically diagnosed mood and anxiety symptoms. Participants' symptoms of physiological anxiety, hoarding, and eating pathology fell within the subclinical range. Overall, the number of individuals exceeding validated clinical cutoffs was between 3 and 19 times the estimated 12-month prevalence rates. Based on the current findings, it is argued that MTurk participants differ from the general population in meaningful ways, and researchers should consider this when referring to this sample as truly representative. (PsycINFO Database Record
Hoarding disorder (HD) is characterized by difficulty discarding, clutter, and frequently excessive acquiring. Theories have pointed to intense negative emotional reactions (e.g., sadness) as one factor that may play a critical role in HD’s etiology. Preliminary work with an analogue sample indicated that more intense negative emotions following emotional films were linked with greater hoarding symptoms. Symptom provocation imaging studies with HD patients have also found evidence for excessive activation in brain regions implicated in processing emotions. The current study utilized a sample with self-reported serious hoarding difficulties to examine how hoarding symptoms related to both general and hoarding-related emotional reactivity, taking into account the specificity of these relationships. We also examined how two cognitive factors, fear of decision-making and confidence in memory, modified this relationship. 628 participants with self-identified hoarding difficulties completed questionnaires about general emotional reactivity, depression, anxiety, decision-making, and confidence in memory. To assess hoarding-related emotional reactivity, participants reported their emotional reactions when imagining discarding various items. Heightened general emotional reactivity and more intense emotional reactions to imagined discarding were associated with both difficulty discarding and acquisition, but not clutter, controlling for age, gender, and co-occurring mood and anxiety symptoms. Fear of decision-making and confidence in memory interacted with general emotional reactivity to predict hoarding symptoms. These findings provide support for cognitive-behavioral models of hoarding. Experimental research should be conducted to discover whether emotional reactivity increases vulnerability for HD. Future work should also examine whether emotional reactivity should be targeted in interventions for hoarding.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.